AgMedica more than doubles production, expands facilities in southwestern Ontario

A medical cannabis company is expanding its sales and production capabilities in southwestern Ontario.

Capacity will increase to more than 26 thousand kilograms

Some of the plants growing at AgMedica, a medicinally focused cannabis producer in Chatham-Kent. (Chris Ensing/CBC)

A medical cannabis company is expanding its sales and production capabilities in southwestern Ontario.

AgMedica Biosience Inc. has acquired two new indoor processing facilities — one in Chatham and one in London. 

CEO Trevor Henry said the company is well-positioned if Health Canada approves the sale of cannabis-infused beverages or edibles.

"We're actually building a plane as we're flying it," he said. "But you know what, when you have confidence in your team, and you're moving through the regulatory hurdles very quickly, we think we're very well-positioned."

London's 100,000 square-foot location will be used for processing, packaging and bottling. The new 300,000 square-foot Chatham facility will be used for future cannabis-plant cultivation.

AgMedica already has a Chatham footprint with their Riverview cultivation site. The 200,000 square-foot site currently produces 6,000 kg of cannabis a year.

CEO Trevor Henry stands inside of one of the grow rooms at the AgMedica Riverview Cultivation facility. (Chris Ensing/CBC)

The Riverview location is a former automotive plant along the Thames River. The medical cannabis company was selected as a supplier for Ontario Cannabis Stores in August.

Plans to expand this facility are in progress, which will up its capacity to more than 26 thousand kilograms and allow it to produce for third-party licensed producers as well.

Altogether AgMedica now has five facilities with almost 800,000 square-foot of production and cultivation.


To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.